Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Clinical trial NCT04205812 · COMPLETED

Trial details

NCT number: NCT04205812
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Squamous Non-Small Cell Lung Cancer Metastatic Nonsquamous Non-Small Cell Lung Cancer

Start date: 2020-09-11
Primary completion: 2023-12-15
Enrollment: 583

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.